The anti-inflammatory drugs segment is currently taking the lead in the neuroinflammation market, and I think this reflects how widely these therapies are still being used to manage inflammation linked to central nervous system disorders.
In 2025, the segment accounted for around 32 percent of the neuroinflammation market, generating approximately USD 2.75 billion in revenue. Based on current projections, it could reach nearly USD 6.19 billion by 2035, growing at a CAGR of 7.8 percent during the forecast period.
Download Sample: https://www.precedenceresearch.com/sample/8435
What stands out to me is that conventional anti-inflammatory treatments continue to play an important role despite the growing focus on newer therapies. The segment includes widely used drug categories such as non-steroidal anti-inflammatory drugs, corticosteroids, and cytokine inhibitors.
Cytokine-targeting treatments are gaining more attention as researchers and healthcare providers look for ways to address inflammation more specifically. At the same time, the demand for affordable treatment options continues to support the use of established anti-inflammatory medicines.
Another factor contributing to the segment’s position is the availability of some anti-inflammatory medications over the counter. Easy access can increase their use, particularly when patients are looking for familiar and relatively accessible treatment options.
From my perspective, the growth of this segment shows that established therapies still have an important place in neuroinflammation treatment. While research continues to bring new approaches to the field, the continued demand for accessible and cost-effective anti-inflammatory drugs is likely to keep this segment relevant in the years ahead.
Overall, I see this as a good example of how traditional treatments can continue to grow alongside newer developments in neurological care.
Buy This Report: https://www.precedenceresearch.com/checkout/8435
About US
At Precedence Research, we deliver specialized healthcare market research, healthcare consulting, pharmaceutical market intelligence, biotechnology research, medical device market analysis, and life sciences consulting to help organizations stay ahead in a rapidly evolving healthcare ecosystem. Our experts provide data-driven industry insights, market forecasts, competitive analysis, regulatory intelligence, clinical research insights, digital health analysis, and custom healthcare consulting that enable healthcare companies, investors, and innovators to identify growth opportunities, optimize strategies, and make confident business decisions.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Quick Contact:
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04 and +65 31065601
Visit Our Website: https://www.precedenceresearch.com